Theralase Technologies Inc. V.TLT

Alternate Symbol(s): TLTFF

Healthcare Medical Devices

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.

TSXV:TLT - Post by User

Theralase Technologies Inc. > New Press Release - Theralase(R) Demonstrates 8 Year Shelf Life of Lead Drug Ruvidar(TM)

<< Previous

Bullboard Posts

Next >>

Comment by StevenBirchon Sep 29, 2023 8:23am

258 Views

Post# 35661152

RE:RE:New Press Release - Theralase(R) Demonstrates 8 Year Shelf Life of Lead Drug Ruvidar(TM)

Yes this is aimed at potential partners and finally we may be past the monthly/quarterly news releases.

I get the feeling that when they mentioned they had submitted the pre-BTD that THEY got the feeling that BTD was just a matter of when not if because these news releases are all about the future of Ruvidar.

I can't wait for THAT news release!

99942Apophis wrote:
PressRelease wrote:
TORONTO, ON / ACCESSWIRE / September 29, 2023 /Theralase Technologies Inc. ("Theralase" or the "Company") (TSXV:TLT)(OTCQB:TLTFF) is a clinical stage pharmaceutical company that is dedicated to the research and development of light and radiation activated Photo Dynamic Compounds ("PDCs"), their...read article.

Very impressive, reading between the lines to me is if we begin to see NRs every few weeks then it is a build up to the bigger NRs we are expecting. Todays news in my mind is huge in the fact I don't think any other Biopharmaceutical company has a product that can remain potent anywhere close to Ruvidar, please correct me if I'm wrong.
Once again Theralase amazes me!